title: [Compliance with a protocol of prevention of neonatal group B streptococcal sepsis in the Aurore perinatal network].
abstract: OBJECTIVE
  Our purpose was to measure the compliance with the network hospitals protocol for preventing neonatal group B streptococcal sepsis.
  
  
  METHODS
  All vaginal deliveries during a one-week period in 37 maternities of the perinatal network were reviewed retrospectively.
  
  
  RESULTS
  A total of 752 records were reviewed. Compliance with the protocol regarding the time of culture was 91.1%. Overall, prevalence of group B streptococcal carriage was 14.2%. Among patients eligible for intrapartum antibiotics, 46.4% received adequate prophylaxis. Considering the length of labor, one out of two patients could have received intrapartum adequate antibiotics. Regarding newborns, 86.1% received adequate medical surveillance. There was no confirmed case of group B streptococcal sepsis during the week of study.
  
  
  CONCLUSIONS
  All the maternities of network Aurore accepted and adopted evaluation principle. Some elements of protocol could be better applied, in particular delivering adequate intrapartum antibiotic prophylaxis.
authors.affiliation: Coordination du réseau Aurore, Hôpital de la Croix Rousse, Lyon. corinne.dupont@chu-lyon.fr
authors.forename: C
authors.initials: C
authors.lastname: Dupont
authors.forename: S
authors.initials: S
authors.lastname: Touzet
authors.forename: D
authors.initials: D
authors.lastname: Cao
authors.forename: V
authors.initials: V
authors.lastname: Prunaret-Julien
authors.forename: P
authors.initials: P
authors.lastname: Audra
authors.forename: G
authors.initials: G
authors.lastname: Putet
authors.forename: O
authors.initials: O
authors.lastname: Dupuis
authors.forename: R-C
authors.initials: RC
authors.lastname: Rudigoz
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D036861:Delivery, Obstetric; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical; D010349:Patient Compliance; D011247:Pregnancy; D018805:Sepsis / Q000517:prevention & control*; D013290:Streptococcal Infections / Q000517:prevention & control* / Q000635:transmission; D013292:Streptococcus agalactiae
chemical_list: D000900:Anti-Bacterial Agents